Intravenous chloroprocaine attenuates hemodynamic changes associated with direct laryngoscopy and tracheal intubation

Anesthesia and Analgesia

Volumn 90, Issue 5, 2000, Pages 1208-1212

  Durrani, Mehmood ^a   Barwise, John A ^a   Johnson, Raymond F ^a   Kambam, Jay R ^a   Janicki, Piotr K ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPROCAINE; LIDOCAINE; PLACEBO;

ADRENALIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; HEMODYNAMIC MONITORING; HUMAN; LARYNGOSCOPY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0034101664     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200005000-00039     Document Type: Article

References (24)

1. Schnapp M, Mays KS, North WC. Intravenous 2-chloroprocaine in treatment of chronic pain. Anesth Analg 1981;60:844-5.
2. Parris WCV, Gerlock AJ, McDonnell RC. Intraarterial chloroprocaine for the control of pain associated with partial splenic embolization Anesth Analg 1981;60:112-5.
3. Phero JC, McDonald JS, Raj PP, et al. Controlled intravenous administration of chloroprocaine in treatment of chronic pain. Anesth Analg 1981;60:844-5.
4. Pitkanen MT, Suzuki N, Rosenberg PH. Intravenous regional anaesthesia with 0.5% prilocaine or 0.5% chloroprocaine. a double-blind comparison in volunteers. Anaesthesia 1992;47: 618-9.
5. Pitkanen M, Kytta J, Rosenberg PH. Comparison of 2-chloroprocaine and prilocaine for intravenous regional anaesthesia of the arm: a clinical study. Anaesthesia, 1993;48:1091-3.
6. Suzuki N, Pitkanen M, Sariola H, et al. The effect of plain 0.5% 2-chloroprocaine on venous endothelium after intravenous regional anaesthesia in the rabbit. Acta Anaesthesiol Scand 1994; 38:653-6.
7. Janicki PK, Ellis PS, Van Der Watt ML, James MFM. Plasma catecholamine estimation using high performance liquid chromatography with electrochemical detection. Medical Technology SA 1992;6:40-2.
8. Janicki PK, Johnson R, Kambam J. Rapid determination of chloroprocaine and its major metabolite: 2-chloroaminobenzoic acid in plasma by high performance liquid chromatography. J Chrom Biom Appl 1996;675:336-41.
9. Meng QC, Kramer TH, Arthur GR, et al. High performance liquid chromatographic analysis of the 2-chloroprocaine metabolite, diethylaminomethanol, in blood and serum. Reg Anesth Pain Med 1999;24:242-5.
10. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
11. Kalow W, Staron N. On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers. Can J Biochem Physiol 1957;35:1305-20. 1
12. Gillespie WR. Noncompartmental versus compartmental modelling in clinical pharmacokinetics. Clin Pharmacokinet 1991;20: 253-62.
13. Colonna-Romano P, Lingaraju N, Braitman LE. Epidural test dose: lidocaine 100 mg, not chloroprocaine, is a symptomatic marker of i.v. injection in labouring parturients. Can J Anaesth 1993;40:714-7.
14. Mulroy MF, Neal JM, Mackey DC, Harrington BE. 2-chloroprocaine an bupivacaine are unreliable indicators of intravascular injection in the premedicated patient. Reg Anesth Pain Med 1998;23:9-13.
15. Rathmell JP, Viscomi CM, Ashikaga T. Detection of intravascular epidural catheters using 2-chloroprocaine: influence of local anesthetic dose and nalbuphine premedication. Reg Anesth 1997;22:113-8.
16. Ackerman WE, Phero JC, Juneja MM. Panic disorders following 2-chloroprocaine. Am J Psychiatry 1989;146:940-1.
17. Marcus NJ, Padawer WJ. Re-experienced sexual abuse as 'side effect' or cure following intravenous 2-chloroprocaine. Pain 1991;47:122-3.
18. Phero JC, Ackerman WE, Wulsin LR. A brief psychotic reaction during the administration of intravenous 2-chloroprocaine for the treatment of chronic pain. Pain 1990;43:349-52.
19. Rosenberg PH, Zou J, Heavner JE. Comparison of acute central nervous system and cardiovascular toxicity of 2-chloroprocaine and prilocaine in the rat. Acta Anaesthesiol Scand 1993;37: 751-5.
20. Kalichman MW, Moorhouse DF, Powell HC, Myers RR Relative neural toxicity of local anesthetics. J Neuropathol Exp Neurol 1993;52:234-40.
21. Franks W, Janicki P, Horn JL, et al. Comparative antidysrhythmic properties of local anesthetics drugs in rats [abstract]. Anesthesiology 1999;81:A532.
22. Janicki PK, Durrani M, Brock J, et al. Chloroprocaine pharmacokinetics study using a high performance liquid chromatography method in humans [abstract]. Anesthesiology 1996;85:A313.
23. O'Brien JE, Abbey V, Hinsvark O, et al. Metabolism and measurement of chloroprocaine, an ester-type local anesthetic. J Pharm Sci 1979;68:75-8.
24. Janicki PK, Kambam JR, Johnson R. The effect of plasma cholinesterase inhibition on chloroprocaine elimination in dogs [abstract]. Anesth Analg 1994;78:2S.